TIDMCTEC

RNS Number : 3272M

ConvaTec Group PLC

07 May 2020

ConvaTec Group Plc

Results of Annual General Meeting

Reading, United Kingdom 7 May 2020 - Poll Result

ConvaTec Group Plc ("ConvaTec"), a leading global medical products and technologies company, held its annual general meeting today ("Meeting"), The results of the poll held in relation to the resolutions proposed at the Meeting are set out below.

 
                                      For                   Against           Total Votes     % of      Number 
                                  (see note 2)            (see note 2)                         ISC     of Votes 
                                                                                              Voted    Withheld 
                                                                                                       (see note 
                                                                                                           3 
 Resolution                  No of shares    %        No of Shares   % 
                            --------------  -------  -------------  ------ 
      Receive Annual 
       Report and 
 1     Accounts              1,689,253,478    99.99        162,424    0.01   1,689,415,902    85.17    1,375,861 
     ---------------------  --------------  -------  -------------  ------  --------------  -------  ----------- 
      Approve the 
       Directors' 
       Remuneration 
 2     Report                1,459,271,427    86.35    230,658,135   13.65   1,689,929,562    85.20      908,684 
     ---------------------  --------------  -------  -------------  ------  --------------  -------  ----------- 
      Approve the 
       Directors' 
       Remuneration 
 3     Policy                1,479,320,219    87.54    210,611,343   12.46   1,689,931,562    85.20      906,684 
     ---------------------  --------------  -------  -------------  ------  --------------  -------  ----------- 
      Declare Final 
 4     Dividend              1,670,311,992    98.79     20,526,249    1.21   1,690,838,241    85.24            6 
     ---------------------  --------------  -------  -------------  ------  --------------  -------  ----------- 
      Elect John 
       McAdam as 
 5     a director            1,686,038,868    99.72      4,725,844    0.28   1,690,764,712    85.24       73,534 
     ---------------------  --------------  -------  -------------  ------  --------------  -------  ----------- 
      Elect Karim 
       Bitar as 
 6     a director            1,687,089,831    99.78      3,746,388    0.22   1,690,836,219    85.24        2,028 
     ---------------------  --------------  -------  -------------  ------  --------------  -------  ----------- 
      Elect Brian 
       May as a 
 7     director              1,689,080,374    99.90      1,749,450    0.10   1,690,829,824    85.24        8,423 
     ---------------------  --------------  -------  -------------  ------  --------------  -------  ----------- 
      Re-elect 
       Frank Schulkes 
 8     as a director         1,684,095,328    99.60      6,734,291    0.40   1,690,829,619    85.24        8,628 
     ---------------------  --------------  -------  -------------  ------  --------------  -------  ----------- 
      Re-elect 
       Margaret 
       Ewing as 
 9     a director            1,662,219,417    98.31     28,611,702    1.69   1,690,831,119    85.24        7,128 
     ---------------------  --------------  -------  -------------  ------  --------------  -------  ----------- 
      Re-elect 
       Rick Anderson 
 10    as a director         1,686,272,799    99.73      4,561,920    0.27   1,690,834,719    85.24        3,528 
     ---------------------  --------------  -------  -------------  ------  --------------  -------  ----------- 
      Re-elect 
       Regina Benjamin 
 11    as a director         1,678,521,751    99.30     11,891,727    0.70   1,690,413,478    85.22      424,768 
     ---------------------  --------------  -------  -------------  ------  --------------  -------  ----------- 
      Re-elect 
       Ros Rivaz 
 12    as a director         1,630,402,633    96.47     59,672,747    3.53   1,690,075,380    85.21      762,866 
     ---------------------  --------------  -------  -------------  ------  --------------  -------  ----------- 
      Re-elect 
       Sten Scheibye 
 13    as a director         1,687,084,151    99.78      3,745,468    0.22   1,690,829,619    85.24        8,628 
     ---------------------  --------------  -------  -------------  ------  --------------  -------  ----------- 
      Re-appoint 
       Deloitte 
 14    LLP as auditor        1,690,827,240   100.00          9,746    0.00   1,690,836,986    85.24        1,261 
     ---------------------  --------------  -------  -------------  ------  --------------  -------  ----------- 
      Authorise 
       the directors 
       to determine 
       the remuneration 
       of the Company's 
 15    auditor               1,690,692,456   100.00          5,000    0.00   1,690,697,456    85.24      140,791 
     ---------------------  --------------  -------  -------------  ------  --------------  -------  ----------- 
      Authorise 
       political 
       donations 
       and political 
 16    expenditure           1,679,778,558    99.35     11,050,957    0.65   1,690,829,515    85.24        8,732 
     ---------------------  --------------  -------  -------------  ------  --------------  -------  ----------- 
      Authorise 
       allotment 
 17    of shares             1,576,731,448    93.28    113,598,212    6.72   1,690,329,660    85.22      508,587 
     ---------------------  --------------  -------  -------------  ------  --------------  -------  ----------- 
      Disapply 
       pre-emption 
 18    rights*               1,665,615,258    98.53     24,844,432    1.47   1,690,459,690    85.23      378,557 
     ---------------------  --------------  -------  -------------  ------  --------------  -------  ----------- 
      Disapply 
       pre-emption 
       rights in 
       connection 
       with an acquisition 
       or specified 
 19    capital investment*   1,664,010,440    98.44     26,449,249    1.56   1,690,459,689    85.23      378,557 
     ---------------------  --------------  -------  -------------  ------  --------------  -------  ----------- 
      Authorise 
       purchase 
 20    of own shares*        1,669,151,425    98.76     20,937,729    1.24   1,690,089,154    85.21      749,092 
     ---------------------  --------------  -------  -------------  ------  --------------  -------  ----------- 
      Call general 
       meetings 
       on 14 days' 
 21    notice*               1,663,148,185    98.36     27,687,156    1.64   1,690,835,341    85.24        2,906 
     ---------------------  --------------  -------  -------------  ------  --------------  -------  ----------- 
 

*Special Resolution

NOTES:

   1.   All resolutions were passed. 
   2.   Votes "For" and "Against" are expressed as a percentage of votes received. 

3. A "Vote withheld" is not a vote in law and is not counted in the calculation of the votes "For" or "Against" a resolution.

4. Total number of shares in issue at close of business on 6 May 2020 was 1,983,513,851 shares; 85.24% of voting capital was instructed.

   5.   Computershare acted as scrutineer of the poll on all resolutions. 

In accordance with Listing Rule 9.6.2, copies of the resolutions that do not constitute ordinary business that were passed at the Meeting will be submitted to the National Storage Mechanism and will be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism .

About ConvaTec

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion care. ConvaTec's products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com where a copy of this announcement can also be found.

Enquiries

Analysts and Investors

   Mark Reynolds, Director Investor Relations, ConvaTec            +44 (0)7551 036 625 

ir@convatec.com

Media

   Buchanan: Charles Ryland / Chris Lane / Vicky Hayns             +44 (0)207 466 5000 

ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92

# # #

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

RAGUBAVRRRUVRAR

(END) Dow Jones Newswires

May 07, 2020 11:15 ET (15:15 GMT)

Grafico Azioni Convatec (LSE:CTEC)
Storico
Da Feb 2024 a Mar 2024 Clicca qui per i Grafici di Convatec
Grafico Azioni Convatec (LSE:CTEC)
Storico
Da Mar 2023 a Mar 2024 Clicca qui per i Grafici di Convatec